Contact Dermatitis

• FDA label_change · 2026-03-16
  FDA Approved: DESOXIMETASONE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)

  FDA approved a supplemental application for desoximetasone (Saptalis Pharmaceuticals, LLC.), resulting in updated labeling for this topical …

• FDA label_change · 2016-11-02
  FDA Approved: TRIDESILON CREAM — Supplemental Application (Encore Dermatology Inc)

  FDA approved a supplemental application for Tridesilon Cream (desonide 0.05%), updating the product labeling.

• FDA label_change · 2015-06-29
  FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Actavis Pharma, Inc.)

  FDA approves a supplemental application for clobetasol propionate from Actavis Pharma, Inc. to update the product labeling.

• FDA label_change · 2015-05-21
  FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)

  The FDA approved a supplemental application for CLOBEX (clobetasol propionate) from Galderma Laboratories to update the product labeling.

• FDA label_change · 2012-09-07
  FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)

  FDA approved a supplemental application for CLOBEX (clobetasol propionate) from Galderma Laboratories, L.P. The approval updates the product…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2009-06-10
  FDA Approved: HALOG — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a supplemental application for HALOG (halcinonide cream) from Sun Pharmaceutical, resulting in updated product labeling.

• FDA label_change · 2007-12-12
  FDA Approved: DERMOTIC — Supplemental Application (Royal Pharmaceuticals)

  FDA approved a supplemental application for DERMOTIC (fluocinonide acetate) submitted by Royal Pharmaceuticals, typically resulting in updat…